Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect | Patent Publication Number 20170319667
US 20170319667 A9Publication DateNov 9, 2017
Original AssigneeBotulinum Toxin Research Associates Inc.
Current AssigneeRevance Therapeutics
Inventor/ApplicantsGary E. Borodic
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.